Statistics

Total Visits

Views
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer(legacy) 208
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer(legacy) 110

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer 2 6 6 5 8 3 5

File Downloads

Views

Top Country Views

Views
United States 105
Australia 43
France 17
China 9
Netherlands 8
Germany 5
Ireland 5
Vietnam 5
Argentina 2
Spain 2

Top City Views

Views
Kaleen 28
Ashburn 25
Fairfield 10
Rotterdam 8
Des Moines 7
Buffalo 6
Boardman 5
Hanoi 5
Dublin 4
Cambridge 3